We are live on ! Find out more
Susquehanna International Group

Susquehanna International Group Portfolio holdings

AUM $893B
1-Year Est. Return 36.07%
 

Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.

This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+36.07%
3 Year Est. Return
+111.4%
5 Year Est. Return
+100.96%
10 Year Est. Return
+391.58%
AUM
$347B
AUM Growth
+$49B
Cap. Flow
+$12.7B
Cap. Flow %
3.67%
Top 10 Hldgs %
25.82%
Holding
11,328
New
1,232
Increased
3,827
Reduced
4,449
Closed
1,709

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$1.33B
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$781M
3
TSLA icon
Tesla
TSLA
+$468M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$467M
5
HD icon
Home Depot
HD
+$344M

Sector Composition

Rank Sector Weight
1 Technology 2.15%
2 Consumer Discretionary 1.94%
3 Communication Services 1.82%
4 Financials 1.12%
5 Healthcare 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVIV
9501
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$10K ﹤0.01%
+57
New +$14.2K
GSAT icon
9502
Globalstar
GSAT
$10.8B
$9K ﹤0.01%
1,167
-4,299
-79% -$26K
INDP icon
9503
Indaptus Therapeutics
INDP
$159M
$9K ﹤0.01%
8
-1
-11% -$1.38K
SNES icon
9504
SenesTech
SNES
$6.83M
0
TGB
9505
Trekor Metals
TGB
$3.23B
$9K ﹤0.01%
19,054
+5,040
+36% +$2.13K
VTGN icon
9506
VistaGen Therapeutics
VTGN
$11.9M
$9K ﹤0.01%
456
-16
-3% -$404
CSCI
9507
CALL
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$9K ﹤0.01%
100
-167
-63% -$15.6K
PAVMZ
9508
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$9K ﹤0.01%
23,195
-86,353
-79% -$27.1K
DMK
9509
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$9K ﹤0.01%
190
-535
-74% -$25.9K
SQBG
9510
DELISTED
Sequential Brands Group, Inc.
SQBG
$9K ﹤0.01%
+669
New +$9.73K
FBRX icon
9511
PUT
Forte Biosciences
FBRX
$1.58B
$8K ﹤0.01%
40
-178
-82% -$40.3K
INUV icon
9512
Inuvo
INUV
$17M
$8K ﹤0.01%
2,712
-911
-25% -$2.56K
STAB
9513
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$8K ﹤0.01%
13,922
-7,121
-34% -$5.26K
TKKSR
9514
DELISTED
TKK Symphony Acquisition Corporation Right
TKKSR
$8K ﹤0.01%
+33,645
New +$8.62K
SMTA
9515
CALL
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$8K ﹤0.01%
10,500
IGC icon
9516
IGC Pharma
IGC
$29.3M
$7K ﹤0.01%
10,794
-46,540
-81% -$38.1K
OTLK icon
9517
Outlook Therapeutics
OTLK
$211M
$7K ﹤0.01%
585
-243
-29% -$5.66K
TARA icon
9518
Protara Therapeutics
TARA
$220M
$7K ﹤0.01%
410
-1,491
-78% -$17.1K
THM
9519
International Tower Hill Mines
THM
$740M
$7K ﹤0.01%
12,091
-16,232
-57% -$8.63K
VIVS
9520
VivoSim Labs
VIVS
$1.23M
$7K ﹤0.01%
81
-53
-40% -$4.96K
AMPE
9521
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$7K ﹤0.01%
43
-119
-73% -$15.4K
ENT
9522
DELISTED
Global Eagle Entertainment Inc.
ENT
$7K ﹤0.01%
557
-2,166
-80% -$29.8K
CORV
9523
PUT
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$7K ﹤0.01%
+16,300
New +$27.1K
IDXG
9524
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$7K ﹤0.01%
1,486
-1,434
-49% -$9.28K
WYY icon
9525
WidePoint Corp
WYY
$110M
$6K ﹤0.01%
+1,437
New +$5.19K

Similar funds

Susquehanna International Group's Q4 2019 Portfolio in Review

As of Q4 2019, Susquehanna International Group held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Susquehanna International Group deployed $12.7B of net new capital in Q4 2019, opening 1,232 new positions and adding to 3,827 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Amazon, an estimated $1.36B trimmed.

  • Susquehanna International Group's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
  • Susquehanna International Group added most to Boeing in Q4 2019, an estimated $1.33B increase.
  • Susquehanna International Group's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
  • Susquehanna International Group fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
  • Susquehanna International Group's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
  • Susquehanna International Group opened 1,232 new positions and closed 1,709 in Q4 2019.
  • Susquehanna International Group's portfolio value rose 16% quarter-over-quarter to $347B.

Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.